A very small protein, that could also possibly be organellar (mitochondrial). A transit peptide cannot be excluded in the sequence.. Localization: Mitochondrial (by feature)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 4 |
GO:0016020 | membrane | 2 | 8 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4QHT8
Term | Name | Level | Count |
---|---|---|---|
GO:0008535 | respiratory chain complex IV assembly | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0017004 | cytochrome complex assembly | 6 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 6 | 2 |
GO:0033617 | mitochondrial cytochrome c oxidase assembly | 7 | 2 |
GO:0043933 | protein-containing complex organization | 4 | 2 |
GO:0065003 | protein-containing complex assembly | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 88 | 92 | PF00656 | 0.375 |
CLV_NRD_NRD_1 | 27 | 29 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.557 |
CLV_PCSK_FUR_1 | 52 | 56 | PF00082 | 0.581 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.318 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.371 |
CLV_PCSK_KEX2_1 | 54 | 56 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.467 |
CLV_PCSK_PC1ET2_1 | 22 | 24 | PF00082 | 0.443 |
CLV_PCSK_PC1ET2_1 | 6 | 8 | PF00082 | 0.473 |
CLV_PCSK_PC7_1 | 23 | 29 | PF00082 | 0.420 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.638 |
DOC_MAPK_gen_1 | 67 | 75 | PF00069 | 0.420 |
DOC_PP2B_LxvP_1 | 75 | 78 | PF13499 | 0.427 |
LIG_14-3-3_CanoR_1 | 14 | 21 | PF00244 | 0.668 |
LIG_14-3-3_CanoR_1 | 23 | 31 | PF00244 | 0.565 |
LIG_APCC_ABBA_1 | 44 | 49 | PF00400 | 0.420 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.631 |
LIG_LIR_Gen_1 | 85 | 91 | PF02991 | 0.354 |
LIG_LIR_LC3C_4 | 26 | 31 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 85 | 90 | PF02991 | 0.393 |
LIG_RPA_C_Fungi | 23 | 35 | PF08784 | 0.319 |
LIG_SH2_CRK | 41 | 45 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.593 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.315 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.577 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.269 |
MOD_PIKK_1 | 13 | 19 | PF00454 | 0.437 |
MOD_PK_1 | 55 | 61 | PF00069 | 0.435 |
MOD_PKA_1 | 22 | 28 | PF00069 | 0.642 |
MOD_PKA_2 | 13 | 19 | PF00069 | 0.612 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.633 |
TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.324 |
TRG_ENDOCYTIC_2 | 87 | 90 | PF00928 | 0.475 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.622 |
TRG_ER_diArg_1 | 52 | 55 | PF00400 | 0.544 |
TRG_ER_diArg_1 | 68 | 71 | PF00400 | 0.596 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P760 | Leptomonas seymouri | 66% | 100% |
A0A0S4IM31 | Bodo saltans | 41% | 85% |
A0A3S5H6E0 | Leishmania donovani | 93% | 100% |
A4H5R7 | Leishmania braziliensis | 81% | 100% |
A4HU07 | Leishmania infantum | 93% | 100% |
D0A9H2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9AMT7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |